340 related articles for article (PubMed ID: 31078306)
1. Update on Recurrent Respiratory Papillomatosis.
Derkay CS; Bluher AE
Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
[TBL] [Abstract][Full Text] [Related]
2. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
3. Recurrent respiratory papillomatosis: update 2018.
Derkay CS; Bluher AE
Curr Opin Otolaryngol Head Neck Surg; 2018 Dec; 26(6):421-425. PubMed ID: 30300210
[TBL] [Abstract][Full Text] [Related]
4. Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients.
Tam S; Wu CF; Peng HL; Dahlstrom KR; Sturgis EM; Lairson DR
Laryngoscope; 2020 May; 130(5):1186-1194. PubMed ID: 31194270
[TBL] [Abstract][Full Text] [Related]
5. [Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
Pan XF; Wang J; Xiao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):189-192. PubMed ID: 30808153
[TBL] [Abstract][Full Text] [Related]
6. [Perspectives on recurrent respiratory papillomatosis and human papillomavirus].
Trolle S; Lynggaard CD; Gregersen KG; Baandrup L; Grønhøj C; Buchwald CV
Ugeskr Laeger; 2019 Oct; 181(41):. PubMed ID: 31610833
[TBL] [Abstract][Full Text] [Related]
7. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Watson M; Lowy DR; Markowitz LE
Vaccine; 2012 Sep; 30(42):6016-9. PubMed ID: 22867718
[TBL] [Abstract][Full Text] [Related]
8. HPV and recurrent respiratory papillomatosis: a modern virus and a serious disease with controversial management.
Nikolopoulos TP
Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1917-8. PubMed ID: 24139588
[No Abstract] [Full Text] [Related]
9. Recurrent respiratory papillomatosis: A possible role for the HPV vaccine?
Lively JM; Shah RK
JAAPA; 2013 May; 26(5):48, 51-3. PubMed ID: 23682456
[No Abstract] [Full Text] [Related]
10. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
Sullivan C; Curtis S; Mouzakes J
Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
[TBL] [Abstract][Full Text] [Related]
12. Toward prevention or cure for recurrent respiratory papillomatosis.
Hughes OR
Laryngoscope; 2012 Dec; 122 Suppl 4():S63-4. PubMed ID: 23254606
[No Abstract] [Full Text] [Related]
13. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
14. Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea.
Oh JK; Choi HY; Han M; Jung YS; Lee SJ; Ki M
Epidemiol Health; 2021; 43():e2021019. PubMed ID: 33906285
[TBL] [Abstract][Full Text] [Related]
15. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
16. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates.
Novakovic D; Cheng AT; Baguley K; Walker P; Harrison H; Soma M; Malloy M; Brotherton JM
Laryngoscope; 2016 Dec; 126(12):2827-2832. PubMed ID: 27074766
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
Nyirjesy S; Osmundson P; Matrka L
J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
[TBL] [Abstract][Full Text] [Related]
18. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
20. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
